Latest Technology News

Battery Age Minerals has joined the U.S. Defense Industrial Base Consortium, positioning itself at the forefront of securing critical germanium supply amid escalating export restrictions from China. The company’s dual-continental assets in Austria and Utah and its technology initiatives aim to address strategic vulnerabilities in defence and semiconductor supply chains.

Iluka Resources scaled back mineral sands output in Q1 2026 amid operational idling and market caution, while capital expenditure on its Eneabba rare earths refinery hit $977 million with commissioning progressing.

Asian Battery Metals has completed its acquisition of the Maikhan Uul Copper-Gold Project in Mongolia and is set to begin a 1,500-metre drilling campaign targeting gold mineralisation and feeder zones. The move complements its nearby Yambat project and signals an aggressive exploration push in 2026.

StepChange Holdings delivered a robust $15.18 million in unaudited revenue and $1.46 million EBITDA in Q3 2026, driven by organic growth and the BroadReach acquisition. Margin improvements and AI integration highlight its evolving consulting model.

Brazilian Critical Minerals (ASX: BCM) has boosted the indicated mineral resource at its Ema rare earth project by 58%, now totalling 1.07 billion tonnes at 732 ppm TREO. This positions Ema as one of the world’s largest ionic clay rare earth deposits and the only ISR-ready project in the western world.

Advanced Braking Technology Ltd (ASX: ABV) reported a 28% jump in product sales revenue to $6 million for Q3 FY26, driven by strong aftermarket sales and international market traction. The company also advanced certification of its autonomous BRAKEiQ system, targeting FY27 adoption.

Invion Limited is broadening its non-melanoma skin cancer trial to include basal cell carcinoma patients following encouraging safety and efficacy data from squamous cell carcinoma cohorts, targeting the largest skin cancer segment.

Sunrise Energy Metals has confirmed strong economics for its Syerston Scandium Project with a US$120 million feasibility study, targeting 60 tonnes per year of scandium oxide and potential expansion to 180 tonnes. The project benefits from US government financing interest and rising global demand amid Chinese export restrictions.

Starpharma has secured FDA alignment on the clinical development plan for its DEP® HER2 radiotherapy candidate, paving the way for a first-in-human phase 1 study in advanced HER2-positive cancers scheduled for H2 2026.

Compumedics maintains robust sales momentum but faces FY26 revenue timing challenges due to MEG installation delays and a cautious Somfit D rollout. The company expects solid year-on-year growth and positions for improved execution in FY27.

Pure Resources has deepened its partnership with Rice University to develop carbon nanotube fibre thermal management technology aimed at AI and defence markets, leveraging its Garnet Hills graphite for a vertically integrated IP pipeline.

AdAlta, Oribiotech, and Cell Therapies have inked a Memorandum of Understanding to deploy Oribiotech’s IRO automated cell therapy manufacturing platform in Australia and Asia Pacific, aiming to slash costs and boost production speed for CAR-T therapies.